ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,203Medicare Part D Prescriptions Filled, Including Refills

Rank: 96 out of 1006

$925K Total Retail Price of All Prescriptions

Rank: 50 out of 1006

457 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
67% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 457 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

5% of this provider’s 457 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 7,060 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$91 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
SIMVASTATIN 431 288 1 1
LEVOTHYROXINE SODIUM 321 250 2 2
OMEPRAZOLE 276 190 3 9
LISINOPRIL 271 150 4 3
ATORVASTATIN CALCIUM 254 205 5 5
FUROSEMIDE 230 213 6 6
WARFARIN SODIUM 183 158 7 8
TRAZODONE HCL 173 90 8 21
METOPROLOL TARTRATE 164 151 9 7
METFORMIN HCL 163 106 10 10
RISPERIDONE 160 102 11 40
AMLODIPINE BESYLATE 155 119 12 4
GABAPENTIN 151 70 13 20
CRESTOR 148 130 14 18
NEXIUM 145 54 15 28
OLANZAPINE 145 122 15 68
LISINOPRIL-HYDROCHLOROTHIAZIDE 137 116 17 38
METOPROLOL SUCCINATE 129 102 18 12
DIVALPROEX SODIUM 125 56 19 53
QUETIAPINE FUMARATE 113 70 20 45
HYDROCHLOROTHIAZIDE 112 99 21 11
BENZTROPINE MESYLATE 106 52 R 22 106
TRAMADOL HCL 105 80 23 35
ZOLPIDEM TARTRATE 97 65 24 14
METFORMIN HCL ER 96 87 25 56
CYMBALTA 94 62 26 41
ZETIA 92 60 27 51
CLOZAPINE 91 13 28 107
ESCITALOPRAM OXALATE 87 56 29 27
MIRTAZAPINE 86 38 30 26
TAMSULOSIN HCL 81 76 31 23
BYSTOLIC 80 63 32 84
ADVAIR DISKUS 78 59 33 37
PREDNISONE 75 72 34 33
SERTRALINE HCL 74 25 35 19
LEVEMIR FLEXPEN 73 52 36 173
ATENOLOL 73 73 36 13
LOSARTAN POTASSIUM 69 59 38 22
OXYBUTYNIN CHLORIDE ER 67 65 39 92
LITHIUM CARBONATE 67 55 39 187
PRAVASTATIN SODIUM 65 50 41 15
SPIRIVA 62 55 42 48
OXCARBAZEPINE 61 43 43 199
HYDROCODONE-ACETAMINOPHEN 60 15 S3 44 25
CITALOPRAM HBR 60 43 44 24
FLUOXETINE HCL 60 52 44 85
GLIPIZIDE 59 58 47 69
ALLOPURINOL 57 50 48 31
LOVASTATIN 55 45 49 44
GLIPIZIDE ER 55 55 49 108
LANTUS 55 44 49 43
FLUTICASONE PROPIONATE 53 26 52 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 23, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.